Dosidal · Belgium
Sumatriptan Teva 50 mg
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Belgium |
|---|---|
| Record | be:presentation:cti:292013-08 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | be-cti-extended: 292013-08 be-authorisation: BE292013 |
| Source authority | FAMHP |
| Read date | 2026-11-15T03:58:09Z |
| authorisation status | amp_status: AUTHORIZED ampp_status: AUTHORIZED commercialised_now: False lifecycle: current period_from: 2026-04-03 supply_problem_now: False state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| controlled status | state: unknown |
| identity | amp_code: SAM292013-00 atc: N02CC01 authorisation_number: BE292013 cti_extended: 292013-08 form: Film-coated tablet holder: Teva medicine_type: ALLOPATHIC name: Sumatriptan Teva 50 mg pack: 30 parallel_circuit: 0 parallel_import: False substances: strength: 70.0000 mg substance: Sumatriptan Succinate state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| pack product code | fmd_in_scope: True note: no FMD product code and no CNK in SAM state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| prescription class | as_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006 class: prescription delivery_modus: M1 state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53sBsMcaDR17v1vaR6pHW7aoReOL6z5VJMufh3cFzBZZTFBSWYaGV1qdyJWADWmiVmcqYzrT-zhyS3TLbVI2fLMgVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:292013-08 · Related records in other markets · Dosidal